Prevention and control of zoonotic diseases
The interaction of human with wild animals can lead to varied emerging or re-emerging global zoonotic pandemic such as SARS as well as MERS (Day, 2011). Some of the comprehensive approaches require for the update to prevent zoonotic diseases and to conserve integrity of ecosystem and environment is summarized as follows:
Increased investment in the global human and animal health infrastructure (one health) and protected area assessment plans, especially in South American and Asian countries with low percentage of assessed protected areas for management effectiveness (Dhama et al. 2013).
Furthermore, some of the routes for control zoonotic diseases outbreak is given below:
management practice and biosafety is without, a doubt, are the best way (Hafez, 2005). Another way to control zoonotic diseases would be via the use of vaccination in protected areas local communities, but there is some obstacle such as variability in the strains, difficulty in production, cost constraints, prohibitively expensiveness etc. On the other hand, in animal vaccination, there are basic biological differences that effect on vaccination protocols, between each species and different species (Paul-Pierre, 2009; Dhama et al. 2012a). Moreover, regulations governing registration and marketing of vaccines for wild animals should be flexible and development of science and technology also the new vaccines available needs to be considered for animal disease control recommendations (Moran et al., 2009; Gargano et al. 2013). The drug delivery systems such as nanoparticles, liposoma, the viral vector should be investigated and used to achieve efficient and protective immune responses ((Dhama et al. 2013; Babiuk et al., 2003; Suri et al., 2007). Furthermore, nutrition and nutritional status can have a direct and indirect impact upon the augment immune defenses (Dhama et al. 2013; Mahima et al., 2013).